Pharmacokinetics of ceftazidime, alone or in combination with piperacillin or tobramycin, in the sera of cancer patients.

We administered 2 g of ceftazidime intravenously every 8 h to cancer patients for the empiric therapy of febrile episodes. Ceftazidime was administered as monotherapy for patients with granulocyte counts in excess of 1,000/microliter. Febrile, neutropenic patients were randomized to also receive eit...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	Antimicrob Agents Chemother
Autori principali:	Drusano, G L, Joshi, J, Forrest, A, Ruxer, R, Standiford, H, Leslie, J, Wade, J, Schimpff, S
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Microbiology (ASM) 1985
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180104/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3890730/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.605
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!